Alzheimer's disease onset tied to lapses in attention, study suggestsNovember 10, 2005People in early stages of Alzheimer's disease have greater difficulty shifting attention back and forth between competing sources of information, a finding that offers new support for theories that contend breakdowns in attention play an important role in the onset of the disease. "Our results provide evidence that breakdowns in attention produce a clear change in the early stages of Alzheimer's-related dementia," said study co-author David A. Balota, a professor of psychology in Arts & Sciences at Washington University in St. Louis. Routine tasks that require the shifting of attention, such as driving a car while conversing with a passenger, may become more challenging for people in very early stages of Alzheimer's disease, suggests a new study from Washington University in St. Louis. Published in a recent issue of the journal Neuropsychology, the study suggests that subtle breakdowns in attention may offer a reliable clue that a patient is grappling with early symptoms of Alzheimer's-related dementia. The findings are important because they offer clinicians and researchers another tool by which to better predict and understand dementia of the Alzheimer's type early in its history. Psychologists focus on early detection in part because current medications are useful only when given very early in the course of the disease. While it's well known that memory skills deteriorate as Alzheimer's progresses, recent research by Balota and Duchek, among others, have championed the notion that breakdowns in attention may be at the heart of many cognitive problems linked to Alzheimer's. Although memory problems also show up in early stages of the disease, this study suggests that underlying declines in attention may be contributing to these memory mishaps and to other cognitive difficulties often associated with the disease. "Because attention is prerequisite for memory, one might suspect that attention is one of the contributing culprits, at least early on in the disease," suggests study lead author Janet M. Duchek, an associate professor of psychology. Participants for the study were drawn from volunteers at the Alzheimer's Disease Research Center at Washington University. Duchek and Balota studied 94 older participants, average age mid-70s, who were healthy control individuals or individuals diagnosed with very mild, or mild dementia of the Alzheimer's type. In an effort to gauge each group's ability to effectively monitor and switch among competing channels of information, Duchek and Balota relied on a well-established psychological testing technique know as the dichotic listening task. The Dichotomy Developed in the 1950s, the dichotic listening test plays off the fact that humans are hardwired to process sensory information in a cross-lateral fashion-words heard in the left ear tend to be processed in the right hemisphere of the brain, and vice-versa. Since the left hemisphere of the brain is typically dominant for language processing, words presented in the right ear often have an advantage over words presented simultaneously in the left ear - the right ear-left hemisphere processing channel is said to be "pre-potent" in that it has a default processing advantage over the left ear-right hemisphere channel. Using the dichotic listening task, Duchek and Balota presented participants with distinct streams of audio information via headphones. One stream of information - computer-generated speech naming three digits (such as 4, 3, 1) - went to the left ear; a different stream (such as 9, 2, 5) went to the right ear. By asking participants to recall numbers in the order they were presented to either ear, the researchers were able to measure an individual's ability to switch back and forth between right-left processing channels, and more importantly, to monitor how well attention skills allowed them to overcome the "pre-potent" tendency to favor information presented to the default right ear-left hemisphere language channel. As predicted, people with early dementia tended to rely more often on the default channel, reporting digits presented to the right ear far better than they reported digits presented to the left ear. When the researchers controlled for overall recall performance, the mild dementia group recalled 21.7% more information from their right ear vs. left ear, and even the very mildly affected group recalled 11.3% more from the right ear. The control participants only recalled 5.8% more from the right vs. left ear. The right-ear advantage increased with dementia severity. People farther along in the disease relied even more on the dominant left-side channel; in other words, they found it even harder to override the usual path to process what went through the left ear to the right brain. Poor attentional control can leave people falling back on familiar, pre-programmed information pathways. The study confirms that very early in the disease, people have problems with selective attention. This problem, although not as obvious as memory loss, may also explain why early-stage patients start to struggle with everyday tasks that call for processing a lot of information, such as driving. This speculation is supported by prior findings that performance on dichotic listening predicts accident rates in commercial bus drivers. Findings from this study, the research team suggests, converge with accumulating evidence that individuals with early stage Alzheimer's Disease have breakdowns controlling prepotent pathways across a variety of experimental paradigms, which place minimal demands on memory systems. "Our hope," Duchek said, "is that this work increases recognition that Alzheimer's Disease is not simply a disease of memory." Washington University in St. Louis |
|||||||||||||||||||||
| Related Alzheimer Disease Current Events and Alzheimer Disease News Articles Delirium in hospitalized adults: Situation critical, no relief available Every year as many as seven million adults in the United States experience delirium during hospitalization. New data demonstrate potential for early detection of Alzheimer's disease Data published in the June issue of the Journal of Alzheimer's Disease demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress (OS) levels in blood plasma, which may prove to be a useful biomarker in the early detection of Alzheimer's disease. Another McGill/JGH breakthrough opens door to early Alzheimer's diagnosis A new diagnostic technique which may greatly simplify the detection of Alzheimer's disease has been discovered by researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital (JGH). Measuring brain atrophy in patients with mild cognitive impairment Scientists at the University of California, San Diego School of Medicine have shown that a fully automated procedure called Volumetric MRI - which measures the "memory centers" of the brain and compares them to expected size - is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease. Commonly used medications may produce cognitive impairment in older adults Many drugs commonly prescribed to older adults for a variety of common medical conditions including allergies, hypertension, asthma, and cardiovascular disease appear to negatively affect the aging brain causing immediate but possibly reversible cognitive impairment, including delirium, in older adults. Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug. New test for mysterious metabolic diseases developed at Stanford/Packard Scientists at Stanford University School of Medicine have devised a much-needed way to monitor and find treatments for a mysterious and devastating group of metabolic diseases that arise from mutations in cells' fuel-burning mechanism. Recalibrating 'fight or flight' A Canadian/U.S. research team has reported a novel approach to stimulating recovery from chronic stress disorders. Details of the therapeutic model, which exploits the natural dynamics of the body's "fight or flight" system, are published January 23 in the open-access journal PLoS Computational Biology Vitamin B does not slow cognitive decline in Alzheimer's A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease. Protecting patient privacy the new fashioned way Protecting patient privacy has been recognized as the duty of health-care providers for about as long as doctors have seen patients. In 1996 that duty became a legal obligation when Congress passed the Health Insurance Portability and Accountability Act. More Alzheimer Disease Current Events and Alzheimer Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||